M&A Activity • Sep 3, 2014
M&A Activity
Open in ViewerOpens in native device viewer
News Details
Corporate | 3 September 2014 09:43
Eckert & Ziegler takes over Brazilian isotope specialists – stronger presence in South America
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Acquisition
03.09.2014 / 09:43
Berlin, September, 3, 2014. Eckert & Ziegler Strahlen- und Medizintechnik AG acquired the Isotope business unit of REM Indústria e Comércio Ltda. (REM), based in Sao Paulo, Brazil, effective September 1, 2014 via its subsidiary Eckert & Ziegler Isotope Products Holdings GmbH. The approximately 30 employees have been integrated into TOF Comercial Ltda. (TOF), Sao Paulo, which Eckert & Ziegler has also acquired and has been renamed as Eckert & Ziegler Brasil Comercial Ltda. and does business as Eckert & Ziegler Brasil Isotope Solutions.
TOF specializes in importing isotope technology to Brazil and is one of the leading providers of nuclear medical components in South America. The company has been selling Eckert & Ziegler products for decades. It has nationwide sales structures and all the required local authorizations to handle substances based on isotope technology.
“Eckert & Ziegler is focusing on organic growth as well as strategic acquisitions in the expansion of its business. This acquisition fits well into our growth strategy in South America, one of the world’s most dynamic healthcare markets. The expanded sales structures also result in promising market opportunities for the Radiopharma and Radiation Therapy segments,” said Frank Yeager, Head of the Isotope Products segment of Eckert & Ziegler AG.
About Eckert & Ziegler
With almost 700 employees, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is one of the world’s largest providers of components based on isotope technology for radiation therapy and nuclear medicine.
Contributing to saving lives.
If you have any questions, please contact:
Eckert & Ziegler AG
Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138
03.09.2014 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | 49 30 941084-138 |
| Fax: | 49 30 941084-112 |
| E-mail: | [email protected] |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, Düsseldorf, Hamburg, München |
| End of News | DGAP News-Service |
| - - - |
| 285310 03.09.2014 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.